| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8214414 | International Journal of Radiation Oncology*Biology*Physics | 2016 | 8 Pages |
Abstract
Our results suggest that DNA-PKcs could be a predictive marker of BCR after brachytherapy, and this might be a useful tool for optimizing the choice of treatment in low-risk PCa patients.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Sarah MD, Stéphane MD, Alexandre PA-C, Céline MD, Jacques MD, PhD, Gaëlle MD, PhD,